Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
16.15
+0.40 (2.54%)
Dec 15, 2025, 1:57 PM EST - Market open
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $173.88 million as of December 15, 2025. Its market cap has increased by 265.29% in one year.
Market Cap
173.88M
Enterprise Value
109.06M
1-Year Change
265.29%
Ranking
Category
Stock Price
$16.15
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $173.88M, a decrease of -93.06%. That is a compound annual growth rate of -38.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 169.57M | 144.88% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | 2.40B | -4.35% |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |